The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between beta-catenin (CTNNB1) mutations and clinical outcomes of pembrolizumab in advanced hepatocellular carcinoma (aHCC): Exploratory analyses from KEYNOTE-240.
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai; Roche
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); Eisai (Inst); GE Healthcare (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; Eisai; Genentech/Roche; Ipsen; IQVIA; MSD; Omega Therapeutics, Inc.; Ono Pharmaceutical; Roche
 
Philippe Merle
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Roche
Research Funding - Ipsen
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Thomas Decaens
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Gilead Sciences; Ipsen; Roche/Genentech
Research Funding - Enyo Pharma (Inst); Genoscience Pharma (Inst); Guerbet (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Gen (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Astellas Pharma; Bristol-Myers Squibb (Inst); Gen (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Teva (Inst)
 
Olav Dajani
No Relationships to Disclose
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Jean-Marie Peron
No Relationships to Disclose
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Eisai; MSD
Travel, Accommodations, Expenses - Ipsen; Roche
 
Jennifer J. Knox
Honoraria - AstraZeneca; Incyte; Ipsen; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Bruno Daniele
Honoraria - AstraZeneca; Eisai; Incyte; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Roche; Xenthera Inc.
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD
 
Leah Suttner
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Andrea L Webber
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Carol Elaine Pena
Employment - Merck
Stock and Other Ownership Interests - Bayer; Merck
Patents, Royalties, Other Intellectual Property - Patents from work at Bayer as a Bayer employee
 
Razvan Cristescu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Cai Chen
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ken Hatogai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Abby B. Siegel
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Hengrui Therapeutics; Lilly; Medivir; Medivir; Merck; Pfizer
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)